This pharmaceutical secondary standard can also be used as follows:
- Development of three spectrophotometric methods to determine meloxicam in its pharmaceutical formulations
- Voltammetric determination of meloxicam in pharmaceutical formulations using a boron-doped diamond electrode (BDDE)
- High-performance liquid chromatography-based quantitative analysis of meloxicam in its different tablet formulations
- Development and validation of a reversed-phase HPLC method for the separation and estimation of meloxicam in its pharmaceutical dosage forms
- Quantification of meloxicam and piroxicam from plasma samples using a liquid chromatography method combined with UV detection